The Thrombospondin-1/CD47 signaling axis serve as potential markers of immune checkpoint blockade response modulating immune cell bioenergetics in the tumor microenvironment.

被引：0
|
作者：
Stirling, Elizabeth [1 ]
Wilson, Adam [1 ]
Kooshki, Mitra [1 ]
Yamaleyeva, Lilya [1 ]
Jin, Guanxu [1 ]
Zhang, Wei [1 ]
Miller, Lance [1 ]
Triozzi, Pierre [1 ]
Soto-Pantoja, David [1 ]
机构：
[1] Wake Forest Sch Med, Ctr Comprehens Canc, Winston Salem, NC 27101 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O8
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Targeting the CD47/thrombospondin-1 signaling axis regulates immune cell bioenergetics in the tumor microenvironment to potentiate antitumor immune response
    Stirling, Elizabeth R.
    Terabe, Masaki
    Wilson, Adam S.
    Kooshki, Mitra
    Yamaleyeva, Liliya M.
    Alexander-Miller, Martha A.
    Zhang, Wei
    Miller, Lance D.
    Triozzi, Pierre L.
    Soto-Pantoja, David R.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (11)
  • [2] CD47 and thrombospondin-1 contribute to immune evasion by Porphyromonas gingivalis
    Angabo, Sarah
    Pandi, Karthikeyan
    David, Keren
    Steinmetz, Orit
    Makkawi, Hasnaa
    Farhat, Maria
    Eli-Berchoer, Luba
    Darawshi, Nadeem
    Kawasaki, Hiromichi
    Nussbaum, Gabriel
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (47)
  • [3] CD47 in the Immune Response: Role of Thrombospondin and SIRP-α Reverse Signaling
    Sarfati, Marika
    Fortin, Genevieve
    Raymond, Marianne
    Susin, Santos
    CURRENT DRUG TARGETS, 2008, 9 (10) : 842 - 850
  • [4] Thrombospondin-1:CD47 signaling contributes to the development of T cell exhaustion in cancer
    Weng, Chien-Huan
    Assouvie, Anais
    Dong, Lauren
    Beltra, Jean-Christophe
    Budhu, Sadna
    Mangarin, Levi
    Marouf, Yacine
    Morgado-Palacin, Lucia
    Liu, Cailian
    Monette, Sebastien
    Khan, Jonathan
    Schulze, Isabell
    Zamarin, Dmitriy
    Hamadene, Linda
    Samaan, Fadi
    Hirschhorn, Daniel
    Pourpe, Stephane
    Schroder, David
    Zappasodi, Roberta
    Holland, Pamela
    Anandasabapathy, Niroshana
    Wherry, John
    Wolchok, Jedd D.
    Merghoub, Taha
    CANCER IMMUNOLOGY RESEARCH, 2025, 13 (02)
  • [5] Blockade of the innate immune checkpoint CD47 decreases infarct size by modulation of oxidative stress and immune response
    Korste, S.
    Stock, P.
    Hendgen-Cotta, U. B.
    Rassaf, T.
    Totzeck, M.
    EUROPEAN HEART JOURNAL, 2021, 42 : 3253 - 3253
  • [6] Signaling Regulatory Protein (SIRP)α-CD47 Blockade Joins the Ranks of Immune Checkpoint Inhibition
    Veillette, Andre
    Tang, Zhenghai
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (12) : 1012 - +
  • [7] Thrombospondin-1 signaling through CD47 regulates cell and tissue radiosensitivity via autophagy
    Soto-Pantoja, David
    Miller, Thomas
    Pendrak, Michael
    DeGraff, William
    Sullivan, Camille
    Ridnour, Lisa
    Abu-Asab, Mones
    Wink, David
    Tsokos, Maria
    Roberts, David
    GLYCOBIOLOGY, 2012, 22 (11) : 1519 - 1520
  • [8] Thrombospondin-1 promotes tumor progression in cutaneous T-cell lymphoma via CD47
    Kamijo, Hiroaki
    Miyagaki, Tomomitsu
    Takahashi-Shishido, Naomi
    Nakajima, Rina
    Oka, Tomonori
    Suga, Hiraku
    Sugaya, Makoto
    Sato, Shinichi
    LEUKEMIA, 2020, 34 (03) : 845 - 856
  • [9] Thrombospondin-1 promotes tumor progression in cutaneous T-cell lymphoma via CD47
    Hiroaki Kamijo
    Tomomitsu Miyagaki
    Naomi Takahashi-Shishido
    Rina Nakajima
    Tomonori Oka
    Hiraku Suga
    Makoto Sugaya
    Shinichi Sato
    Leukemia, 2020, 34 : 845 - 856
  • [10] CD47: The Next Frontier in Immune Checkpoint Blockade for Non-Small Cell Lung Cancer
    Lau, Asa P. Y.
    Binstock, Sharon S. Khavkine
    Thu, Kelsie L.
    CANCERS, 2023, 15 (21)
12345